Literature DB >> 8524783

In vitro trans-splicing in Saccharomyces cerevisiae.

A Ghetti1, J N Abelson.   

Abstract

The interactions established at the 5'-splice site during spliceosome assembly are likely to be important for both precise recognition of the upstream intron boundary and for positioning this site in the active center of the spliceosome. Definition of the RNA-RNA and the RNA-protein interactions at the 5' splice site would be facilitated by the use of a small substrate amenable to modification during chemical synthesis. We describe a trans-splicing reaction performed in Saccharomyces cerevisiae extracts in which the 5' splice site and the 3' splice site are on separate molecules. The RNA contributing the 5' splice site is only 20 nucleotides long and was synthesized chemically. The trans-splicing reaction is accurate and has the same sequence, ATP, and Mg2+ requirements as cis-splicing. We also report how deoxy substitutions around the 5'-splice site affect trans-splicing efficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524783      PMCID: PMC40421          DOI: 10.1073/pnas.92.25.11461

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  "Five easy pieces".

Authors:  P A Sharp
Journal:  Science       Date:  1991-11-01       Impact factor: 47.728

2.  Comparison of binding of mixed ribose-deoxyribose analogues of CUCU to a ribozyme and to GGAGAA by equilibrium dialysis: evidence for ribozyme specific interactions with 2' OH groups.

Authors:  P C Bevilacqua; D H Turner
Journal:  Biochemistry       Date:  1991-11-05       Impact factor: 3.162

3.  A computational approach to the mechanism of self-cleavage of hammerhead RNA.

Authors:  H Y Mei; T W Kaaret; T C Bruice
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  5' splice site selection in yeast: genetic alterations in base-pairing with U1 reveal additional requirements.

Authors:  P G Siliciano; C Guthrie
Journal:  Genes Dev       Date:  1988-10       Impact factor: 11.361

5.  A compensatory base change in U1 snRNA suppresses a 5' splice site mutation.

Authors:  Y Zhuang; A M Weiner
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

6.  Trans splicing of mRNA precursors.

Authors:  D Solnick
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

7.  Enhancer-dependent interaction between 5' and 3' splice sites in trans.

Authors:  J P Bruzik; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

8.  DNA cleavage catalysed by the ribozyme from Tetrahymena.

Authors:  D Herschlag; T R Cech
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

9.  Ribozyme recognition of RNA by tertiary interactions with specific ribose 2'-OH groups.

Authors:  A M Pyle; T R Cech
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

10.  A U1 snRNA:pre-mRNA base pairing interaction is required early in yeast spliceosome assembly but does not uniquely define the 5' cleavage site.

Authors:  B Séraphin; L Kretzner; M Rosbash
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

View more
  4 in total

1.  Trans-complementation of the second step of pre-mRNA splicing by exogenous 5' exons.

Authors:  G Chanfreau; C Gouyette; B Schwer; A Jacquier
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

2.  Characterization of U4 and U6 interactions with the 5' splice site using a S. cerevisiae in vitro trans-splicing system.

Authors:  T L Johnson; J Abelson
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

3.  SR proteins are required for nematode trans-splicing in vitro.

Authors:  J R Sanford; J P Bruzik
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

4.  Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver.

Authors:  C Caudevilla; D Serra; A Miliar; C Codony; G Asins; M Bach; F G Hegardt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.